SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: THE ANT who wrote (178600)9/20/2021 11:04:46 AM
From: arun gera  Respond to of 217927
 
<The only way they could make an end run around this was if there were no available alternate treatments.That is why they had to insist that hydroxychloroquine and ivermectin do not work. They had to make sure there was no treatments that worked.>

Convoluted logic.

There were a lot of other treatments that were tried and have some partial success in smaller studies. Regeneron is being used and subsidized.

-Arun


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News